Knowledge (XXG)

Rebound effect

Source đź“ť

126:
hypnotic wears off. Rebound phenomena do not necessarily only occur on discontinuation of a prescribed dosage. Another example is early morning rebound insomnia which may occur when a rapidly eliminated hypnotic wears off which leads to rebounding awakeness forcing the person to become wide awake
66:
that were either absent or controlled while taking a medication, but appear when that same medication is discontinued, or reduced in dosage. In the case of re-emergence, the severity of the symptoms is often worse than pretreatment levels.
49:
that were either absent or controlled while taking a medication, but appear when that same medication is discontinued, or reduced in dosage. In the case of re-emergence, the severity of the symptoms is often worse than pretreatment levels.
139:, due to its selectivity for type1 benzodiazepine receptors and long half-life, does not cause daytime anxiety rebound effects during treatment, showing that half-life is very important for determining whether a nighttime 143:
will cause next-day rebound withdrawal effects or not. Daytime rebound effects are not necessarily mild but can sometimes produce quite marked psychiatric and psychological disturbances.
92:
on its effects in order to fall asleep. Therefore, when a person has stopped taking the medication and is 'rebounding' from its effects, they may experience insomnia as a symptom of
1084: 291:
experienced a rebound. The cause of the rebound is unclear however, since around a third of people with COVID-19 experience a symptom rebound regardless of treatment.
814:
Fernandez, Hubert H.; Martha E. Trieschmann; Michael S. Okun (3 Aug 2004). "Rebound psychosis: Effect of discontinuation of antipsychotics in Parkinson's disease".
171:
and a return of ADHD symptoms but in a temporarily exaggerated form. Up to a third of ADHD children experience a rebound effect when methylphenidate is withdrawn.
466:
Lee A, Lader M (January 1988). "Tolerance and rebound during and after short-term administration of quazepam, triazolam and placebo to healthy human volunteers".
859:"Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse" 306:
can cause a much more severe case of the psoriasis to develop. Therefore, withdrawal should be gradual, until very little actual medication is being applied.
1764: 1634: 1047: 972:"Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function" 1077: 775:"Persistent tardive rebound panic disorder, rebound anxiety and insomnia following paroxetine withdrawal: a review of rebound-withdrawal phenomena" 287:
were published. In May, CDC even issued a health alert informing physicians about "Paxlovid rebounds", which received attention when US president
1907: 184: 96:. Occasionally, this insomnia may be worse than the insomnia the drug was intended to treat. Common medicines known to cause this problem are 1431: 653:
Rosenfeld AA (February 1979). "Depression and psychotic regression following prolonged methylphenidate use and withdrawal: case report".
1070: 1938: 1785: 1234: 544:
Hilbert JM, Battista D (September 1991). "Quazepam and flurazepam: differential pharmacokinetic and pharmacodynamic characteristics".
119: 858: 1487: 372: 731: 1540: 1406: 1497: 1389: 610:
Garland EJ (1998). "Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices and caveats".
1971: 1966: 1891: 1546: 1140: 1718: 423:
Kales A, Soldatos CR, Bixler EO, Kales JD (April 1983). "Early morning insomnia with rapidly eliminated benzodiazepines".
31: 1567: 1400: 1365: 774: 689: 1931: 1795: 1724: 1712: 1370: 1124: 127:
before he or she has had a full night's sleep. One drug which seems to be commonly associated with these problems is
1492: 1205: 1159: 1110: 1096: 320: 1801: 1595: 1360: 1324: 1258: 1242: 1195: 1168: 732:"Effects of stimulants on the continuous performance test (CPT): implications for CPT use and interpretation" 1780: 1412: 1266: 340: 315: 216: 276:
from painkillers when the dose is lowered, the medication wears off, or the drug is abruptly discontinued.
88:
substances taken to relieve primary insomnia. Regular use of these substances can cause a person to become
1866: 1827: 1658: 1556: 1436: 1376: 1355: 1314: 1303: 1247: 1150: 1115: 257: 131:, due to its high potency and ultra short half life, but these effects can occur with other short-acting 1561: 1535: 1345: 1284: 299: 1817: 1590: 1330: 1172: 432: 243: 1850: 1735: 1679: 1669: 1512: 1423: 1277: 1272: 1164: 1135: 325: 188: 168: 164: 89: 1664: 1606: 1395: 894: 839: 635: 592: 526: 388:
Lader, Malcolm (January 1994). "Anxiety or depression during withdrawal of hypnotic treatments".
902: 1707: 1295: 1093: 1028: 1001: 945: 925: 886: 878: 831: 789: 759: 751: 701: 670: 627: 584: 549: 518: 483: 448: 405: 368: 160: 118:
Daytime rebound effects of anxiety, metallic taste, perceptual disturbances which are typical
1897: 1381: 991: 983: 937: 870: 823: 743: 662: 619: 576: 510: 475: 440: 397: 330: 273: 253: 1062: 1702: 1524: 1155: 1129: 335: 156: 109: 93: 17: 567:
Adam K; Oswald I (May 1989). "Can a rapidly-eliminated hypnotic cause daytime anxiety?".
436: 1772: 1462: 1218: 996: 971: 514: 361: 295: 269: 180: 132: 123: 115:
Rebound depression may appear to arise in patients previously free of such an illness.
59: 30:
This article is about the pharmacological term. For the energy conservation term, see
1960: 1119: 941: 874: 747: 479: 401: 220: 212: 192: 843: 639: 596: 530: 1618: 898: 112:
and which are prescribed to people having difficulties falling or staying asleep.
1858: 1809: 248: 97: 623: 1945: 1502: 1456: 987: 236: 152: 105: 926:"Rebound hypertension after discontinuation of transdermal clonidine therapy" 882: 797: 1839: 709: 444: 303: 288: 232: 128: 1032: 1005: 890: 835: 793: 755: 705: 631: 580: 949: 666: 588: 553: 522: 487: 452: 409: 211:
Sudden and severe emergence or re-emergence of psychosis may appear when
1912: 1753: 1748: 1647: 1629: 1476: 1335: 674: 284: 280: 200: 140: 136: 101: 85: 81: 1878: 1579: 196: 63: 46: 827: 1691: 1048:"Covid rebound can happen even in people who haven't taken Paxlovid" 231:
Rebound hypertension, above pre-treatment level, was observed after
279:
In 2022, reports of viral RNA and symptom rebound in people with
501:
Kales A (1990). "Quazepam: hypnotic efficacy and side effects".
1066: 1019:
Maizels M (December 2004). "The patient with daily headaches".
924:
Metz, Stewart; Catherine Klein; Nancy Morton (January 1987).
773:
Bhanji NH, Chouinard G, Kolivakis T, Margolese HC (2006).
62:
rebound phenomenon, is the emergence or re-emergence of
1923: 1877: 1838: 1747: 1690: 1646: 1617: 1578: 1523: 1475: 1449: 1422: 1344: 1313: 1294: 1257: 1233: 1226: 1217: 1183: 1103: 730:Riccio CA, Waldrop JJ, Reynolds CR, Lowe P (2001). 360: 1630:Acute intoxication from hallucinogens (bad trip) 1078: 8: 122:can occur the next day after a short-acting 1635:Hallucinogen persisting perception disorder 1230: 1223: 1085: 1071: 1063: 359:Reber, Arthur S.; Reber, Emily S. (2001). 995: 84:that occurs following discontinuation of 688:Smucker WD, Hedayat M (September 2001). 1765:Kindling (sedative–hypnotic withdrawal) 351: 1908:Chronic solvent-induced encephalopathy 869:(1). John Wiley & Sons A/S: 3–13. 45:, is the emergence or re-emergence of 1432:Alcohol-induced respiratory reactions 7: 857:Moncrieff, Joanna (23 March 2006). 294:Abrupt withdrawal of highly potent 1939:Anabolic-androgenic steroids abuse 1568:Synthetic cannabinoid use disorder 690:"Evaluation and treatment of ADHD" 515:10.1002/j.1875-9114.1990.tb02545.x 120:benzodiazepine withdrawal symptoms 25: 1488:Caffeine-induced anxiety disorder 976:Child Adolesc Psychiatr Clin N Am 390:Journal of Psychosomatic Research 1541:Cannabinoid hyperemesis syndrome 930:The American Journal of Medicine 875:10.1111/j.1600-0447.2006.00787.x 748:10.1176/appi.neuropsych.13.3.326 480:10.1097/00004850-198801000-00002 1498:Caffeine-induced sleep disorder 1390:Fetal alcohol spectrum disorder 736:J Neuropsychiatry Clin Neurosci 1892:Sudden sniffing death syndrome 1547:Intravenous marijuana syndrome 1141:Post-acute-withdrawal syndrome 863:Acta Psychiatrica Scandinavica 1: 1719:Opioid-induced endocrinopathy 1046:Reynolds Lewis (2022-08-02). 32:Rebound effect (conservation) 1932:Anabolic-androgenic steroids 1459:(alcohol use disorder (AUD)) 1401:Positional alcohol nystagmus 1366:Alcohol-related brain damage 942:10.1016/0002-9343(87)90371-8 612:J. Psychopharmacol. (Oxford) 509:(1): 1–10, discussion 10–2. 402:10.1016/0022-3999(94)90142-2 1796:Benzodiazepine use disorder 1725:Opioid-induced constipation 1713:Opioid-induced hyperalgesia 1407:Wernicke–Korsakoff syndrome 1371:Alcohol withdrawal syndrome 1160:Substance-related disorders 1125:Substance-induced psychosis 1097:substance-related disorders 1988: 1493:Caffeine-induced psychosis 1424:Respiratory tract diseases 1409:(WKS, Korsakoff psychosis) 1206:Combined drug intoxication 624:10.1177/026988119801200410 321:Supersensitivity psychosis 29: 18:Rebound withdrawal effects 1802:Benzodiazepine dependence 1786:Benzodiazepine withdrawal 1596:Prenatal cocaine exposure 1259:Gastrointestinal diseases 988:10.1016/j.chc.2007.11.010 970:Vitiello B (April 2008). 396:(Supplement 1): 113–123. 227:Alpha-2 adrenergic agents 1361:Alcoholic polyneuropathy 1325:Alcohol-related dementia 1243:Alcoholic cardiomyopathy 1196:Polysubstance dependence 1169:Psychological dependence 468:Int Clin Psychopharmacol 363:Dictionary of Psychology 1781:Benzodiazepine overdose 1413:Wernicke encephalopathy 1267:Alcoholic liver disease 1235:Cardiovascular diseases 445:10.1126/science.6131538 341:Unintended consequences 316:Disuse supersensitivity 252:) can lead to constant 58:The rebound effect, or 1867:Amphetamine dependence 1828:Barbiturate dependence 1659:Green Tobacco Sickness 1557:Amotivational syndrome 1437:Alcoholic lung disease 1377:Alcoholic hallucinosis 1356:Alcoholic hallucinosis 1304:Alcoholic ketoacidosis 1248:Alcohol flush reaction 1116:Substance intoxication 581:10.1055/s-2007-1014592 258:rhinitis medicamentosa 1972:Psychiatric diagnosis 1967:Clinical pharmacology 1562:Cannabis use disorder 1285:Auto-brewery syndrome 667:10.1176/ajp.136.2.226 367:. Penguin Reference. 244:topical decongestants 151:Rebound effects from 1818:Barbiturate overdose 1591:Cocaine intoxication 1331:Alcohol intoxication 1173:Substance dependence 782:Can J Clin Pharmacol 242:Continuous usage of 187:, can cause rebound 80:Rebound insomnia is 27:Pharmacological term 1851:Stimulant psychosis 1736:Opioid use disorder 1680:Nicotine dependence 1670:Nicotine withdrawal 1513:Caffeine dependence 1273:Alcoholic hepatitis 1165:Physical dependence 1136:Neonatal withdrawal 437:1983Sci...220...95K 326:Physical dependence 268:Another example of 203:when discontinued. 165:stimulant psychosis 1665:Nicotine poisoning 1607:Cocaine dependence 1536:Cannabis arteritis 1396:Korsakoff syndrome 1296:Endocrine diseases 816:Movement Disorders 569:Pharmacopsychiatry 548:. 52 Suppl: 21–6. 76:Sedative hypnotics 43:rebound phenomenon 1954: 1953: 1708:Opioid withdrawal 1471: 1470: 1445: 1444: 982:(2): 459–74, xi. 905:on 5 January 2013 828:10.1002/mds.20260 546:J Clin Psychiatry 264:Other medications 239:discontinuation. 161:dextroamphetamine 16:(Redirected from 1979: 1898:Toluene toxicity 1382:Delirium tremens 1278:Zieve's syndrome 1231: 1224: 1087: 1080: 1073: 1064: 1058: 1057: 1055: 1054: 1043: 1037: 1036: 1027:(12): 2299–306. 1021:Am Fam Physician 1016: 1010: 1009: 999: 967: 961: 960: 958: 956: 921: 915: 914: 912: 910: 901:. Archived from 854: 848: 847: 811: 805: 804: 802: 796:. Archived from 779: 770: 764: 763: 758:. Archived from 727: 721: 720: 718: 717: 708:. Archived from 694:Am Fam Physician 685: 679: 678: 650: 644: 643: 607: 601: 600: 564: 558: 557: 541: 535: 534: 498: 492: 491: 463: 457: 456: 420: 414: 413: 385: 379: 378: 366: 356: 331:Rebound headache 274:rebound headache 254:nasal congestion 21: 1987: 1986: 1982: 1981: 1980: 1978: 1977: 1976: 1957: 1956: 1955: 1950: 1919: 1880: 1873: 1834: 1752: 1743: 1703:Opioid overdose 1686: 1642: 1613: 1574: 1519: 1467: 1441: 1418: 1347: 1340: 1317:system diseases 1316: 1309: 1290: 1253: 1213: 1185: 1179: 1156:Substance abuse 1099: 1091: 1061: 1052: 1050: 1045: 1044: 1040: 1018: 1017: 1013: 969: 968: 964: 954: 952: 923: 922: 918: 908: 906: 856: 855: 851: 813: 812: 808: 800: 777: 772: 771: 767: 729: 728: 724: 715: 713: 687: 686: 682: 655:Am J Psychiatry 652: 651: 647: 609: 608: 604: 566: 565: 561: 543: 542: 538: 503:Pharmacotherapy 500: 499: 495: 465: 464: 460: 422: 421: 417: 387: 386: 382: 375: 358: 357: 353: 349: 336:Drug withdrawal 312: 296:corticosteroids 266: 229: 209: 181:antidepressants 177: 175:Antidepressants 157:methylphenidate 149: 110:benzodiazepines 78: 73: 56: 35: 28: 23: 22: 15: 12: 11: 5: 1985: 1983: 1975: 1974: 1969: 1959: 1958: 1952: 1951: 1949: 1948: 1943: 1942: 1941: 1927: 1925: 1921: 1920: 1918: 1917: 1916: 1915: 1913:Inhalant abuse 1910: 1902: 1901: 1900: 1895: 1885: 1883: 1875: 1874: 1872: 1871: 1870: 1869: 1855: 1854: 1853: 1844: 1842: 1836: 1835: 1833: 1832: 1831: 1830: 1822: 1821: 1820: 1806: 1805: 1804: 1799: 1790: 1789: 1788: 1783: 1773:benzodiazepine 1769: 1768: 1767: 1758: 1756: 1745: 1744: 1742: 1741: 1740: 1739: 1730: 1729: 1728: 1722: 1716: 1710: 1705: 1696: 1694: 1688: 1687: 1685: 1684: 1683: 1682: 1674: 1673: 1672: 1667: 1662: 1652: 1650: 1644: 1643: 1641: 1640: 1639: 1638: 1632: 1623: 1621: 1615: 1614: 1612: 1611: 1610: 1609: 1601: 1600: 1599: 1593: 1584: 1582: 1576: 1575: 1573: 1572: 1571: 1570: 1565: 1559: 1551: 1550: 1549: 1544: 1538: 1529: 1527: 1521: 1520: 1518: 1517: 1516: 1515: 1507: 1506: 1505: 1500: 1495: 1490: 1481: 1479: 1473: 1472: 1469: 1468: 1466: 1465: 1463:Binge drinking 1460: 1453: 1451: 1447: 1446: 1443: 1442: 1440: 1439: 1434: 1428: 1426: 1420: 1419: 1417: 1416: 1410: 1404: 1398: 1393: 1387: 1386: 1385: 1379: 1368: 1363: 1358: 1352: 1350: 1342: 1341: 1339: 1338: 1333: 1328: 1321: 1319: 1311: 1310: 1308: 1307: 1300: 1298: 1292: 1291: 1289: 1288: 1282: 1281: 1280: 1275: 1263: 1261: 1255: 1254: 1252: 1251: 1245: 1239: 1237: 1228: 1221: 1215: 1214: 1212: 1211: 1210: 1209: 1200: 1199: 1198: 1189: 1187: 1181: 1180: 1178: 1177: 1176: 1175: 1162: 1148: 1147: 1146: 1145: 1144: 1138: 1127: 1122: 1107: 1105: 1101: 1100: 1092: 1090: 1089: 1082: 1075: 1067: 1060: 1059: 1038: 1011: 962: 916: 849: 822:(1): 104–105. 806: 803:on 2006-04-12. 765: 762:on 2012-07-14. 722: 680: 645: 602: 559: 536: 493: 458: 431:(4592): 95–7. 415: 380: 373: 350: 348: 345: 344: 343: 338: 333: 328: 323: 318: 311: 308: 270:pharmaceutical 265: 262: 228: 225: 213:antipsychotics 208: 207:Antipsychotics 205: 176: 173: 148: 145: 133:hypnotic drugs 124:benzodiazepine 77: 74: 72: 69: 60:pharmaceutical 55: 52: 39:rebound effect 26: 24: 14: 13: 10: 9: 6: 4: 3: 2: 1984: 1973: 1970: 1968: 1965: 1964: 1962: 1947: 1944: 1940: 1937: 1936: 1934: 1933: 1929: 1928: 1926: 1922: 1914: 1911: 1909: 1906: 1905: 1903: 1899: 1896: 1893: 1890: 1889: 1887: 1886: 1884: 1882: 1876: 1868: 1865: 1864: 1862: 1860: 1856: 1852: 1849: 1848: 1846: 1845: 1843: 1841: 1837: 1829: 1826: 1825: 1823: 1819: 1816: 1815: 1813: 1811: 1807: 1803: 1800: 1797: 1794: 1793: 1791: 1787: 1784: 1782: 1779: 1778: 1776: 1774: 1770: 1766: 1763: 1762: 1760: 1759: 1757: 1755: 1750: 1746: 1737: 1734: 1733: 1731: 1726: 1723: 1720: 1717: 1714: 1711: 1709: 1706: 1704: 1701: 1700: 1698: 1697: 1695: 1693: 1689: 1681: 1678: 1677: 1675: 1671: 1668: 1666: 1663: 1660: 1657: 1656: 1654: 1653: 1651: 1649: 1645: 1636: 1633: 1631: 1628: 1627: 1625: 1624: 1622: 1620: 1616: 1608: 1605: 1604: 1602: 1597: 1594: 1592: 1589: 1588: 1586: 1585: 1583: 1581: 1577: 1569: 1566: 1563: 1560: 1558: 1555: 1554: 1552: 1548: 1545: 1542: 1539: 1537: 1534: 1533: 1531: 1530: 1528: 1526: 1522: 1514: 1511: 1510: 1508: 1504: 1501: 1499: 1496: 1494: 1491: 1489: 1486: 1485: 1483: 1482: 1480: 1478: 1474: 1464: 1461: 1458: 1455: 1454: 1452: 1448: 1438: 1435: 1433: 1430: 1429: 1427: 1425: 1421: 1414: 1411: 1408: 1405: 1402: 1399: 1397: 1394: 1391: 1388: 1383: 1380: 1378: 1375: 1374: 1372: 1369: 1367: 1364: 1362: 1359: 1357: 1354: 1353: 1351: 1349: 1343: 1337: 1334: 1332: 1329: 1326: 1323: 1322: 1320: 1318: 1312: 1305: 1302: 1301: 1299: 1297: 1293: 1286: 1283: 1279: 1276: 1274: 1271: 1270: 1268: 1265: 1264: 1262: 1260: 1256: 1249: 1246: 1244: 1241: 1240: 1238: 1236: 1232: 1229: 1225: 1222: 1220: 1216: 1207: 1204: 1203: 1201: 1197: 1194: 1193: 1191: 1190: 1188: 1186:substance use 1182: 1174: 1170: 1166: 1163: 1161: 1157: 1154: 1153: 1152: 1149: 1142: 1139: 1137: 1134: 1133: 1131: 1128: 1126: 1123: 1121: 1120:Drug overdose 1117: 1114: 1113: 1112: 1109: 1108: 1106: 1102: 1098: 1095: 1088: 1083: 1081: 1076: 1074: 1069: 1068: 1065: 1049: 1042: 1039: 1034: 1030: 1026: 1022: 1015: 1012: 1007: 1003: 998: 993: 989: 985: 981: 977: 973: 966: 963: 951: 947: 943: 939: 935: 931: 927: 920: 917: 904: 900: 896: 892: 888: 884: 880: 876: 872: 868: 864: 860: 853: 850: 845: 841: 837: 833: 829: 825: 821: 817: 810: 807: 799: 795: 791: 788:(1): e69–74. 787: 783: 776: 769: 766: 761: 757: 753: 749: 745: 742:(3): 326–35. 741: 737: 733: 726: 723: 712:on 2008-05-13 711: 707: 703: 700:(5): 817–29. 699: 695: 691: 684: 681: 676: 672: 668: 664: 660: 656: 649: 646: 641: 637: 633: 629: 625: 621: 618:(4): 385–95. 617: 613: 606: 603: 598: 594: 590: 586: 582: 578: 574: 570: 563: 560: 555: 551: 547: 540: 537: 532: 528: 524: 520: 516: 512: 508: 504: 497: 494: 489: 485: 481: 477: 473: 469: 462: 459: 454: 450: 446: 442: 438: 434: 430: 426: 419: 416: 411: 407: 403: 399: 395: 391: 384: 381: 376: 374:0-14-051451-1 370: 365: 364: 355: 352: 346: 342: 339: 337: 334: 332: 329: 327: 324: 322: 319: 317: 314: 313: 309: 307: 305: 301: 297: 292: 290: 286: 283:treated with 282: 277: 275: 272:rebound is a 271: 263: 261: 259: 255: 251: 250: 245: 240: 238: 234: 226: 224: 223:too rapidly. 222: 218: 214: 206: 204: 202: 198: 194: 193:panic attacks 190: 186: 182: 174: 172: 170: 166: 162: 158: 154: 146: 144: 142: 138: 134: 130: 125: 121: 116: 113: 111: 107: 103: 99: 95: 91: 87: 83: 75: 70: 68: 65: 61: 53: 51: 48: 44: 40: 33: 19: 1930: 1857: 1808: 1771: 1619:Hallucinogen 1346:Neurological 1094:Psychoactive 1051:. Retrieved 1041: 1024: 1020: 1014: 979: 975: 965: 953:. Retrieved 936:(1): 17–19. 933: 929: 919: 907:. Retrieved 903:the original 866: 862: 852: 819: 815: 809: 798:the original 785: 781: 768: 760:the original 739: 735: 725: 714:. Retrieved 710:the original 697: 693: 683: 661:(2): 226–8. 658: 654: 648: 615: 611: 605: 575:(3): 115–9. 572: 568: 562: 545: 539: 506: 502: 496: 474:(1): 31–47. 471: 467: 461: 428: 424: 418: 393: 389: 383: 362: 354: 293: 278: 267: 249:nasal sprays 247: 241: 230: 221:discontinued 210: 183:, including 178: 150: 117: 114: 79: 57: 42: 38: 36: 1859:amphetamine 1810:barbiturate 256:, known as 106:anxiolytics 98:eszopiclone 1961:Categories 1840:Stimulants 1503:Caffeinism 1457:Alcoholism 1130:Withdrawal 1053:2022-08-04 955:5 December 716:2009-04-27 347:References 300:clobetasol 298:, such as 237:guanfacine 189:depression 169:depression 153:stimulants 147:Stimulants 94:withdrawal 54:Definition 1946:Chocolate 1348:disorders 883:1600-0447 304:psoriasis 289:Joe Biden 233:clonidine 129:triazolam 90:dependent 1879:Volatile 1754:hypnotic 1749:Sedative 1648:Nicotine 1525:Cannabis 1477:Caffeine 1336:Hangover 1184:Combined 1033:15617293 1006:18295156 891:16774655 844:11574536 836:15390047 794:16456219 756:11514638 706:11563573 640:38304694 632:10065914 597:32045254 531:33505418 310:See also 285:Paxlovid 281:COVID-19 217:switched 201:insomnia 163:include 155:such as 141:hypnotic 137:Quazepam 108:such as 102:zolpidem 86:sedative 82:insomnia 71:Examples 64:symptoms 47:symptoms 1924:Related 1881:solvent 1692:Opioids 1580:Cocaine 1373:(AWS): 1315:Nervous 1269:(ALD): 1219:Alcohol 1104:General 997:2408826 950:3026180 899:6267180 589:2748714 554:1680120 523:1969151 488:2895786 453:6131538 433:Bibcode 425:Science 410:7799243 197:anxiety 1935:: SUD 1894:(SSDS) 1637:(HPPD) 1392:(FASD) 1143:(PAWS) 1031:  1004:  994:  948:  897:  889:  881:  842:  834:  792:  754:  704:  675:760559 673:  638:  630:  595:  587:  552:  529:  521:  486:  451:  408:  371:  235:, and 199:, and 104:, and 1798:(BUD) 1738:(OUD) 1727:(OIC) 1721:(OIE) 1715:(OIH) 1661:(GTS) 1598:(PCE) 1564:(CUD) 1543:(CHS) 1403:(PAN) 1384:(DTs) 1327:(ARD) 1306:(AKA) 1287:(ABS) 1250:(AFR) 1208:(CDI) 909:3 May 895:S2CID 840:S2CID 801:(PDF) 778:(PDF) 636:S2CID 593:S2CID 527:S2CID 185:SSRIs 179:Many 41:, or 1904:SUD 1888:SID 1863:SUD 1847:SID 1824:SUD 1814:SID 1792:SUD 1777:SID 1761:SID 1732:SUD 1699:SID 1676:SUD 1655:SID 1626:SID 1603:SUD 1587:SID 1553:SUD 1532:SID 1509:SUD 1484:SID 1415:(WE) 1202:SID 1192:SUD 1029:PMID 1002:PMID 957:2012 946:PMID 911:2009 887:PMID 879:ISSN 832:PMID 790:PMID 752:PMID 702:PMID 671:PMID 628:PMID 585:PMID 550:PMID 519:PMID 484:PMID 449:PMID 406:PMID 369:ISBN 302:for 215:are 37:The 1450:SUD 1227:SID 1151:SUD 1111:SID 992:PMC 984:doi 938:doi 871:doi 867:114 824:doi 744:doi 663:doi 659:136 620:doi 577:doi 511:doi 476:doi 441:doi 429:220 398:doi 219:or 159:or 1963:: 1171:/ 1167:/ 1158:/ 1132:: 1118:/ 1025:70 1023:. 1000:. 990:. 980:17 978:. 974:. 944:. 934:82 932:. 928:. 893:. 885:. 877:. 865:. 861:. 838:. 830:. 820:20 818:. 786:13 784:. 780:. 750:. 740:13 738:. 734:. 698:64 696:. 692:. 669:. 657:. 634:. 626:. 616:12 614:. 591:. 583:. 573:22 571:. 525:. 517:. 507:10 505:. 482:. 470:. 447:. 439:. 427:. 404:. 394:38 392:. 260:. 195:, 191:, 167:, 135:. 100:, 1861:: 1812:: 1775:: 1751:/ 1086:e 1079:t 1072:v 1056:. 1035:. 1008:. 986:: 959:. 940:: 913:. 873:: 846:. 826:: 746:: 719:. 677:. 665:: 642:. 622:: 599:. 579:: 556:. 533:. 513:: 490:. 478:: 472:3 455:. 443:: 435:: 412:. 400:: 377:. 246:( 34:. 20:)

Index

Rebound withdrawal effects
Rebound effect (conservation)
symptoms
pharmaceutical
symptoms
insomnia
sedative
dependent
withdrawal
eszopiclone
zolpidem
anxiolytics
benzodiazepines
benzodiazepine withdrawal symptoms
benzodiazepine
triazolam
hypnotic drugs
Quazepam
hypnotic
stimulants
methylphenidate
dextroamphetamine
stimulant psychosis
depression
antidepressants
SSRIs
depression
panic attacks
anxiety
insomnia

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑